{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T14:10:58Z","timestamp":1769091058776,"version":"3.49.0"},"reference-count":51,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,1,10]],"date-time":"2020-01-10T00:00:00Z","timestamp":1578614400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007287","name":"Worldwide Cancer Research","doi-asserted-by":"publisher","award":["16-1153"],"award-info":[{"award-number":["16-1153"]}],"id":[{"id":"10.13039\/501100007287","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.03074","type":"journal-article","created":{"date-parts":[[2020,1,10]],"date-time":"2020-01-10T16:15:56Z","timestamp":1578672956000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Microenvironment-Dependent Gradient of CTL Exhaustion in the AE17sOVA Murine Mesothelioma Tumor Model"],"prefix":"10.3389","volume":"10","author":[{"given":"Jennifer L.","family":"Hope","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panagiota I.","family":"Spantidea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caoimhe H.","family":"Kiernan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher J.","family":"Stairiker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurine C.","family":"Rijsbergen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marjan","family":"van Meurs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inge","family":"Brouwers-Haspels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yvonne M.","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Delia J.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda M.","family":"Bradley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joachim G. J. V.","family":"Aerts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter D.","family":"Katsikis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2020,1,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"6697","DOI":"10.4049\/jimmunol.0800997","article-title":"Chronic antigen stimulation alone is sufficient to drive CD8+ T cell exhaustion","volume":"182","author":"Bucks","year":"2009","journal-title":"J Immunol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1084\/jem.20150598","article-title":"High antigen levels induce an exhausted phenotype in a chronic infection without impairing T cell expansion and survival","volume":"213","author":"Utzschneider","year":"2016","journal-title":"J Exp Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1146\/annurev-immunol-041015-055318","article-title":"CD8 T cell exhaustion during chronic viral infection and cancer","volume":"37","author":"Mclane","year":"2019","journal-title":"Annu Rev Immunol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/S1074-7613(01)00246-1","article-title":"Increased CD95\/Fas-induced apoptosis of HIV-specific CD8(+) T cells","volume":"15","author":"Mueller","year":"2001","journal-title":"Immunity"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e1003658","DOI":"10.1371\/journal.ppat.1003658","article-title":"Type I interferon upregulates Bak and contributes to T cell loss during human immunodeficiency virus (HIV) infection","volume":"9","author":"Fraietta","year":"2013","journal-title":"PLoS Pathog"},{"key":"B6","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1056\/NEJMoa1305133","article-title":"Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma","volume":"369","author":"Hamid","year":"2013","journal-title":"N Engl J Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1056\/NEJMoa1507643","article-title":"Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer","volume":"373","author":"Borghaei","year":"2015","journal-title":"N Engl J Med"},{"key":"B8","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1056\/NEJMoa1501824","article-title":"Pembrolizumab for the treatment of non-small-cell lung cancer","volume":"372","author":"Garon","year":"2015","journal-title":"N Engl J Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1016\/S0140-6736(17)31601-X","article-title":"Pembrolizumab versus ipilimumab for advanced melanoma: final overall survival results of a multicentre, randomised, open-label phase 3 study (KEYNOTE-006)","volume":"390","author":"Schachter","year":"2017","journal-title":"Lancet"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1158\/2159-8290.CD-18-0367","article-title":"Fundamental mechanisms of immune checkpoint blockade therapy","volume":"8","author":"Wei","year":"2018","journal-title":"Cancer Discov"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1056\/NEJMoa1709684","article-title":"Overall survival with combined nivolumab and ipilimumab in advanced melanoma","volume":"377","author":"Wolchok","year":"2017","journal-title":"N Engl J Med"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1126\/science.271.5256.1734","article-title":"Enhancement of antitumor immunity by CTLA-4 blockade","volume":"271","author":"Leach","year":"1996","journal-title":"Science"},{"key":"B13","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/nrc3239","article-title":"The blockade of immune checkpoints in cancer immunotherapy","volume":"12","author":"Pardoll","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"B14","doi-asserted-by":"publisher","first-page":"5051","DOI":"10.4049\/jimmunol.171.10.5051","article-title":"IL-2 intratumoral immunotherapy enhances CD8+ T cells that mediate destruction of tumor cells and tumor-associated vasculature: a novel mechanism for IL-2","volume":"171","author":"Jackaman","year":"2003","journal-title":"J Immunol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e0123563","DOI":"10.1371\/journal.pone.0123563","article-title":"Mesothelioma tumor cells modulate dendritic cell lipid content, phenotype and function","volume":"10","author":"Gardner","year":"2015","journal-title":"PLoS ONE"},{"key":"B16","doi-asserted-by":"publisher","first-page":"4599","DOI":"10.4049\/jimmunol.1001972","article-title":"Dendritic cells and CD28 costimulation are required to sustain virus-specific CD8+ T cell responses during the effector phase in vivo","volume":"186","author":"Dolfi","year":"2011","journal-title":"J Immunol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"3429","DOI":"10.1073\/pnas.89.8.3429","article-title":"HLA-A2-peptide complexes: refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides","volume":"89","author":"Garboczi","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"B18","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/cyto.a.21015","article-title":"SPICE: exploration and analysis of post-cytometric complex multivariate datasets","volume":"79","author":"Roederer","year":"2011","journal-title":"Cytometry A"},{"key":"B19","doi-asserted-by":"publisher","first-page":"8413","DOI":"10.1128\/JVI.74.18.8413-8424.2000","article-title":"Differential dynamics of CD4(+) and CD8(+) T-lymphocyte proliferation and activation in acute simian immunodeficiency virus infection","volume":"74","author":"Kaur","year":"2000","journal-title":"J Virol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/82_2014_397","article-title":"The effector T cell response to influenza infection","volume":"386","author":"Hufford","year":"2015","journal-title":"Curr Top Microbiol Immunol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/ni.2035","article-title":"T cell exhaustion","volume":"12","author":"Wherry","year":"2011","journal-title":"Nat Immunol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/0092-8674(94)90169-4","article-title":"T cell receptor antagonist peptides induce positive selection","volume":"76","author":"Hogquist","year":"1994","journal-title":"Cell"},{"key":"B23","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1146\/annurev.immunol.25.022106.141609","article-title":"Immunosuppressive strategies that are mediated by tumor cells","volume":"25","author":"Rabinovich","year":"2007","journal-title":"Annu Rev Immunol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.smim.2016.01.002","article-title":"Enhancing T cell therapy by overcoming the immunosuppressive tumor microenvironment","volume":"28","author":"Arina","year":"2016","journal-title":"Semin Immunol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cellimm.2017.04.005","article-title":"Tumor promoting role of anti-tumor macrophages in tumor microenvironment","volume":"316","author":"Goswami","year":"2017","journal-title":"Cell Immunol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"20209","DOI":"10.3390\/ijms151120209","article-title":"Microenvironment of tumor-draining lymph nodes: opportunities for liposome-based targeted therapy","volume":"15","author":"Chandrasekaran","year":"2014","journal-title":"Int J Mol Sci"},{"key":"B27","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1089\/lrb.2013.0012","article-title":"Lymphatic function and immune regulation in health and disease","volume":"11","author":"Liao","year":"2013","journal-title":"Lymphat Res Biol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1126\/science.1090148","article-title":"Control of effector CD8+ T cell function by the transcription factor Eomesodermin","volume":"302","author":"Pearce","year":"2003","journal-title":"Science"},{"key":"B29","doi-asserted-by":"publisher","first-page":"15818","DOI":"10.1073\/pnas.2636938100","article-title":"Antigen-driven effector CD8 T cell function regulated by T-bet","volume":"100","author":"Sullivan","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1126\/science.1229620","article-title":"Progenitor and terminal subsets of CD8+ T cells cooperate to contain chronic viral infection","volume":"338","author":"Paley","year":"2012","journal-title":"Science"},{"key":"B31","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/nri3862","article-title":"Molecular and cellular insights into T cell exhaustion","volume":"15","author":"Wherry","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"e1004251","DOI":"10.1371\/journal.ppat.1004251","article-title":"T-bet and Eomes are differentially linked to the exhausted phenotype of CD8+ T cells in HIV infection","volume":"10","author":"Buggert","year":"2014","journal-title":"PLoS Pathog"},{"key":"B33","doi-asserted-by":"publisher","first-page":"5108","DOI":"10.4049\/jimmunol.1302208","article-title":"Programmed death-1 impairs secondary effector lung CD8(+) T cells during respiratory virus reinfection","volume":"193","author":"Erickson","year":"2014","journal-title":"J Immunol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.ccell.2018.03.012","article-title":"T cell dysfunction in cancer","volume":"33","author":"Thommen","year":"2018","journal-title":"Cancer Cell"},{"key":"B35","doi-asserted-by":"publisher","first-page":"e1004380","DOI":"10.1371\/journal.ppat.1004380","article-title":"CD160-associated CD8 T-cell functional impairment is independent of PD-1 expression","volume":"10","author":"Vigano","year":"2014","journal-title":"PLoS Pathog"},{"key":"B36","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1097\/COC.0000000000000239","article-title":"CTLA-4 and PD-1 pathways: similarities, differences, and implications of their inhibition","volume":"39","author":"Buchbinder","year":"2016","journal-title":"Am J Clin Oncol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"e1005490","DOI":"10.1371\/journal.ppat.1005490","article-title":"TIM3 mediates T cell exhaustion during Mycobacterium tuberculosis infection","volume":"12","author":"Jayaraman","year":"2016","journal-title":"PLoS Pathog"},{"key":"B38","doi-asserted-by":"publisher","first-page":"3591","DOI":"10.1158\/0008-5472.CAN-12-4100","article-title":"Dual blockade of PD-1 and CTLA-4 combined with tumor vaccine effectively restores T-cell rejection function in tumors","volume":"73","author":"Duraiswamy","year":"2013","journal-title":"Cancer Res"},{"key":"B39","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1189\/jlb.1212621","article-title":"At the bench: preclinical rationale for CTLA-4 and PD-1 blockade as cancer immunotherapy","volume":"94","author":"Intlekofer","year":"2013","journal-title":"J Leukoc Biol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"e1173299","DOI":"10.1080\/2162402X.2016.1173299","article-title":"Murine mesothelioma induces locally-proliferating IL-10(+)TNF-alpha(+)CD206(-)CX3CR1(+) M3 macrophages that can be selectively depleted by chemotherapy or immunotherapy","volume":"5","author":"Jackaman","year":"2016","journal-title":"Oncoimmunology"},{"key":"B41","doi-asserted-by":"publisher","first-page":"3291","DOI":"10.4049\/jimmunol.181.5.3291","article-title":"Tumor-induced CD11b+Gr-1+ myeloid cells suppress T cell sensitization in tumor-draining lymph nodes","volume":"181","author":"Watanabe","year":"2008","journal-title":"J Immunol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s00262-009-0747-y","article-title":"Tumors induce the formation of suppressor endothelial cells in vivo","volume":"59","author":"Mulligan","year":"2010","journal-title":"Cancer Immunol Immunother"},{"key":"B43","doi-asserted-by":"publisher","first-page":"E28","DOI":"10.3390\/vaccines4030028","article-title":"Regulatory T cells in the tumor microenvironment and cancer progression: role and therapeutic targeting","volume":"4","author":"Chaudhary","year":"2016","journal-title":"Vaccines."},{"key":"B44","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s00109-014-1143-4","article-title":"Human hepatocellular carcinoma-infiltrating CD4(+)CD69(+)Foxp3(-) regulatory T cell suppresses T cell response via membrane-bound TGF-beta1","volume":"92","author":"Han","year":"2014","journal-title":"J Mol Med."},{"key":"B45","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/j.1365-2567.2008.02813.x","article-title":"Mechanisms of regulatory T-cell suppression - a diverse arsenal for a moving target","volume":"124","author":"Sojka","year":"2008","journal-title":"Immunology"},{"key":"B46","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/nri2343","article-title":"How regulatory T cells work","volume":"8","author":"Vignali","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.15252\/emmm.201606914","article-title":"TGF-beta1 secreted by Tregs in lymph nodes promotes breast cancer malignancy via up-regulation of IL-17RB","volume":"9","author":"Huang","year":"2017","journal-title":"EMBO Mol Med"},{"key":"B48","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1038\/s41467-018-04524-x","article-title":"Induction of anergic or regulatory tumor-specific CD4(+) T cells in the tumor-draining lymph node","volume":"9","author":"Alonso","year":"2018","journal-title":"Nat Commun"},{"key":"B49","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1183\/09031936.00101008","article-title":"Local effector failure in mesothelioma is not mediated by CD4+ CD25+ T-regulator cells","volume":"34","author":"Jackaman","year":"2009","journal-title":"Eur Respir J"},{"key":"B50","doi-asserted-by":"publisher","first-page":"2290","DOI":"10.1002\/eji.201142275","article-title":"Antigen amount dictates CD8+ T-cell exhaustion during chronic viral infection irrespective of the type of antigen presenting cell","volume":"42","author":"Richter","year":"2012","journal-title":"Eur J Immunol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"e88328","DOI":"10.1172\/jci.insight.88328","article-title":"Lack of immunoediting in murine pancreatic cancer reversed with neoantigen","volume":"1","author":"Evans","year":"2016","journal-title":"JCI Insight"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.03074\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,10]],"date-time":"2020-01-10T16:15:58Z","timestamp":1578672958000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.03074\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,10]]},"references-count":51,"alternative-id":["10.3389\/fimmu.2019.03074"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.03074","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,10]]},"article-number":"3074"}}